ALLIANCEBERNSTEIN L.P. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 326 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,443,433
-70.5%
51,268
-73.2%
0.00%
-66.7%
Q1 2024$8,286,569
-36.3%
191,155
-25.7%
0.00%
-40.0%
Q4 2023$13,017,819
-5.8%
257,320
-15.5%
0.01%
-16.7%
Q3 2023$13,812,936
-2.9%
304,518
-12.1%
0.01%0.0%
Q2 2023$14,218,454
+718.6%
346,538
+613.0%
0.01%
+500.0%
Q1 2023$1,736,964
-21.4%
48,600
-16.9%
0.00%0.0%
Q4 2022$2,209,696
-14.0%
58,504
+0.7%
0.00%0.0%
Q3 2022$2,570,000
+14.1%
58,102
-4.5%
0.00%0.0%
Q2 2022$2,253,000
-1.8%
60,860
-1.7%
0.00%0.0%
Q1 2022$2,294,000
-27.0%
61,939
-40.0%
0.00%0.0%
Q4 2021$3,141,000
+36.8%
103,214
+50.8%
0.00%0.0%
Q3 2021$2,296,000
-17.5%
68,451
-1.9%
0.00%0.0%
Q2 2021$2,784,000
-19.9%
69,803
-9.7%
0.00%
-50.0%
Q1 2021$3,475,000
-11.0%
77,300
+11.9%
0.00%0.0%
Q4 2020$3,905,000
+18.1%
69,069
-0.9%
0.00%0.0%
Q3 2020$3,306,000
-19.4%
69,669
+0.1%
0.00%0.0%
Q2 2020$4,103,000
+25.9%
69,589
+0.9%
0.00%0.0%
Q1 2020$3,260,000
-22.2%
68,958
-0.6%
0.00%0.0%
Q4 2019$4,192,000
+2.0%
69,392
+1.2%
0.00%
-33.3%
Q3 2019$4,109,000
-6.8%
68,584
-0.0%
0.00%0.0%
Q2 2019$4,409,000
-19.5%
68,601
+1.6%
0.00%
-25.0%
Q1 2019$5,480,000
+41.6%
67,517
-5.7%
0.00%
+33.3%
Q4 2018$3,871,000
+3.9%
71,608
-0.9%
0.00%
+50.0%
Q3 2018$3,727,000
+21.2%
72,253
-2.1%
0.00%0.0%
Q2 2018$3,075,000
-46.9%
73,790
-43.9%
0.00%
-50.0%
Q1 2018$5,796,000
+58.6%
131,487
+81.0%
0.00%
+33.3%
Q4 2017$3,654,000
-1.6%
72,637
-0.8%
0.00%0.0%
Q3 2017$3,713,000
-0.4%
73,237
-0.1%
0.00%0.0%
Q2 2017$3,728,000
+29.6%
73,287
+2.4%
0.00%
+50.0%
Q1 2017$2,877,000
-16.1%
71,579
-0.2%
0.00%
-33.3%
Q4 2016$3,430,000
+24.5%
71,717
-4.7%
0.00%
+50.0%
Q3 2016$2,756,000
+25.0%
75,219
-20.5%
0.00%0.0%
Q2 2016$2,204,000
-36.4%
94,634
+10.6%
0.00%
-33.3%
Q1 2016$3,466,000
-27.2%
85,574
+11.2%
0.00%
-25.0%
Q4 2015$4,764,00076,9220.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Sicart Associates LLC 413,372$26,567,00010.80%
Bellevue Group AG 7,957,128$511,404,0008.73%
TANAKA CAPITAL MANAGEMENT INC 32,670$2,100,0006.43%
DOWLING & YAHNKE LLC 675,478$43,413,0003.60%
First Light Asset Management, LLC 327,132$21,025,0002.92%
Motley Fool Wealth Management, LLC 567,005$36,441,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 82,781$5,320,0001.97%
Opus Point Partners Management, LLC 20,124$1,293,0001.91%
SECTOR GAMMA AS 131,514$8,452,0001.36%
BLB&B Advisors, LLC 183,880$11,818,0001.36%
View complete list of IONIS PHARMACEUTICALS INC shareholders